Donald Trump has been a fierce advocate of the anti-malaria drug hydroxychloroquine as a potential treatment for the coronavirus.
But many people think his interest in the drug can be attributed to the fact that he has a stake in Sanofi, the French firm that makes it.
Doctors in the United States have cautioned against raising false hope, as the effectiveness of hydroxychloroquine has not yet been proved.
Cal Thomas and Marion McKeone discussed this and more from the US, including Trump's offer to help with Boris Johnson's coronavirus treatment.
Listen to the interview in full by pressing the play button on this page.
